glp-1 agonists cardiovascular diseases Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action GLP-1 Receptor Agonists in Heart
Description
doi:10.1126/science.287.5453.664 67
Enhanced follicular development and normalized estrous cycles have been reported in obese rodent models
2024 Apr 4;390(13):1233-1234
Stekovic, S
DPP-4 inhibitors: Focus on safety
23% on placebo) and 63% experienced a BMI reduction of 10% (vs
